CLINICAL_TRIALS trial_result · 2019-11-20

Clinical Trial Update: An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni) [Phase 2]

Phase 2 open-label trial assessing safety and efficacy of a dose-finding regimen in children and infants with schistosomiasis (Schistosoma mansoni).

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Schistosomiasis | Phase 2 | Status: COMPLETED | Results posted: 2019-11-20